Anal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II
Conditions:   Anal Cancer;   Radiotherapy Side Effect Intervention:   Other: Bone sparring radiotherapy Sponsors:   Karen-Lise Garm Spindler;   Herlev Hospital;   Zealand University Hospital;   Vejle Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials